Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. - Geborek, P; Bladstrom, A; Turesson, C (Ann Rheum Dis, 2005)
et al.